Prof. Tjalf Ziemssen talks about Patient-reported Outcomes: Novel Examination Techniques to Uncover Disability Accumulation at ParadigMS Pre-MENACTRIMS Symposium, Abu Dhabi, Dec 7, 2023.
Identification of progression needs new (digital) tools:
•Which can monitor different symptoma domains
•Which can assessment neurological function in a quantitative way
•Which are sensitive enough to detect even subtle changes
Patient-reported outcomes can assist using innovative instruments to detect progression from the patient perspective.
Data should be collected and analyzed on one platform.
BIOGRAPHY
TJALF ZIEMSSEN
Prof. Tjalf Ziemssen, MD, is Professor of Clinical Neuroscience in the Department of Neurology, Head of the Multiple Sclerosis Center and Neuroimmunological Laboratory, and Director of the Division of Neurometabolism at University Clinic Carl-Gustav Carus in Dresden, Germany. He earned his medical degree from the University of Bochum, Germany, and completed his neurology residency from University Hospital of Dresden, and neurobiology fellowship from Max-Planck-Institute of Neurobiology in Martinsried, Germany.
His research is focused on exploring the complex interaction between the neuroendocrinology system and the immune system and psychiatric symptoms, with a particular emphasis on stress in patients with obesity and depression and its pathologic influence on cardiovascular function using animal experimental and clinical approaches.
Dr Ziemssen has authored several articles that have been published in peer-reviewed journals including BMC Neurology, Heart Vessels, Psychoneuroendocrinology, and Annals of Neurology. He is a member of the German Neurological Society, European Neurological Society, and American Academy of Neurology.
Media
